GlassScriptPhysician profile
Krista Tackman
NPI 1770890501
$1,200.62
in general payments reported to CMS, 2019-2025
16 companies · $88.58 in 2025
The $88.58 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $326 · 2022: $495 · 2023: $152 · 2024: $139 · 2025: $88.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $379.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $235.61 | 2021-2022 | |
| Abbvie INC. | $171.25 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $117.34 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $103.05 | 2024 | Voquezna |
| Alkermes, INC. | $88.58 | 2025 | Vivitrol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.51 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $65.11 | 2021-2022 | |
| Amgen INC. | $60.70 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $56.33 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $52.59 | 2021-2022 | |
| Novo Nordisk INC | $43.44 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41.72 | 2022 | |
| Esperion Therapeutics, INC. | $25.22 | 2021-2022 | |
| Pfizer INC. | $18.97 | 2022 | |
| Amarin Pharma, INC. | $17.49 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $16.71 | 2024 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krista Tackman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.